AEterna Zentaris (AEZS) Announces "At-the-Market" Issuance Program
5/22/2013 9:39:30 AM
More...
|
AEterna Zentaris (AEZS) to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto
5/15/2013 7:19:26 AM
More...
|
AEterna Zentaris (AEZS) Announces Election of Directors at Its Annual Meeting of Shareholders
5/9/2013 9:38:44 AM
More...
|
AEterna Zentaris (AEZS) Reports First Quarter 2013 Financial and Operating Results
5/8/2013 7:02:07 AM
More...
|
AEterna Zentaris (AEZS) to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013
5/1/2013 6:36:22 AM
More...
|
AEterna Zentaris (AEZS) Newly Appointed CEO, David A. Dodd, to Host Introductory Analyst and Investor Conference Call on Thursday, April 25, 2013
4/24/2013 6:50:33 AM
More...
|
David A. Dodd Appointed CEO of AEterna Zentaris (AEZS)
4/15/2013 7:46:20 AM
More...
|
David A. Dodd Appointed President & Chief Executive Officer of AEterna Zentaris (AEZS)
4/15/2013 6:39:32 AM
More...
|
AEterna Zentaris (AEZS) Presents Encouraging Updated Data on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at American Association for Cancer Research Meeting
4/11/2013 7:57:11 AM
More...
|
AEterna Zentaris (AEZS) Presents Encouraging Updated Data on Its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at American Association for Cancer Research Meeting
4/10/2013 2:27:58 PM
More...
|
|